Form4insider filings, from the source

SEC Form 4 · accession 0000899243-19-000910

Mirati Therapeutics, Inc. · MRTX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Aaron I. Davis
Director · 10% Owner
Period of report
Jan 7, 2019
Accepted (ET)
Jan 9, 2019 · 9:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001576263

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Jan 7, 2019S16,643$45.47D70,409D
Common StockF2Jan 7, 2019S8,357$46.29D62,052D
Common StockF3Jan 7, 2019S15,000$47.48D47,052D
Common StockF4Jan 8, 2019S5,000$52.20D42,052D
Common StockF5Jan 8, 2019S5,000$53.40D37,052D
Common StockF6holding———1,565,560ISee footnote
Common StockF7holding———513,630ISee footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses